Kevin Lind in

Kevin Lind

Login to view DISC.
Chairman, Board of Directors at Apnimed
📍 San Diego County, California, United States

Kevin Lind is a seasoned biotech executive with over 20 years of experience in life sciences, blending a background in healthcare investment with strategic leadership. As President and CEO, he led Longboard Pharmaceuticals from its inception to a $2. 6 billion acquisition. He holds a BS in Biological Sciences from Stanford and an MBA from UCLA.

He serves as Chairman of the Board for Apnimed and is a board member at Avalo Therapeutics, focusing on sleep apnea and inflammatory diseases, respectively. Kevins career is marked by his instrumental role in company turnarounds, strategic spinouts, and significant capital fundraising exceeding one billion dollars.

Unique fact: He successfully orchestrated the entire lifecycle of Longboard Pharmaceuticals, from spinning it out of Arena Pharmaceuticals to leading its multi-billion dollar acquisition.

Read the full overview →
Experience
24 Years
Current Role
Chairman, Board of Directors
Location
San Diego County, California, United States
Personality Overview

How Kevin shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Kevin cares about

Neurological Drug Development
As CEO of Longboard Pharmaceuticals, he led the development of treatments for rare neurological conditions like Developmental and Epileptic Encephalopathies (DEEs).
Biotech M&A and IPOs
Has extensive experience in corporate transactions, including leading Longboard's IPO and its eventual acquisition, and was CFO of Arena during its acquisition by Pfizer.
+6 more topics Login to view topics
Career

Work history

3-2025
Chairman, Board of Directors
Apnimed
2-2020 - 12-2024
President and CEO
Longboard Pharmaceuticals
6-2016 - 2-2020
CFO
Arena Pharmaceuticals
1-2009 - 3-2016
Principal
TPG Special Situations Partners
2-2006 - 1-2009
Pharma Partners
TPG-Axon Capital
In the press

Media appearances

Apnimed Appoints Kevin R. Lind as Non-Executive Chairman of the Board of Directors. Featured in PR Newswire
See now
Education
2002 - 2004
Master of Business Administration (M.B.A.)
UCLA Anderson School of Management
1994 - 1998
Bachelor of Science (BS)
Stanford University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Apnimed Employees

Explore more public profiles from related professionals.

BW
Barry Wohl
Chief Business Officer
Apnimed
 Sonnie Kang
Sonnie Kang
Vice President, Commercial Strategy
Apnimed
 Steven Xie, MPH
Steven Xie, MPH
Senior Director, Market Development & Go To Market Strategy
Apnimed
 Elaine Liu
Elaine Liu
Senior Director, Medical Communications
Apnimed

More profiles

Discover additional public profiles from our index.

Nora Staka, FCCA, MBA
Nora Staka, FCCA, MBA
Senior Manager
KPMG UK
 Sanjana Dhage
Sanjana Dhage
Candidate Relationship specialist
LPL Financial
 Vandana Negi
Vandana Negi
Associate Manager Human Resources
PW (PhysicsWallah)
 Sneha Sreedhar
Sneha Sreedhar
Head of Business Development
Buynomics
Unlock the full playbookSee exactly how to sell to Kevin. Free, 10 seconds.